Milestones

1. Participation in a multicenter study on retinal detachment, "Improved Outcomes with Heavy Silicone Oil in Complex Primary Retinal Detachment", which analyzes the results of the use of heavy silicone oil in complex primary retinal detachment. This multicenter study has improved knowledge on the efficacy and safety of this technique surgical technique in complex cases, generating great impact. 
2. Incorporation of researchers with Next Generation funding in AI projects and international registries. This incorporation strengthens the team's capacity for the analysis of large volumes of data and the implementation of predictive models, consolidating its leadership in technological innovation in ophthalmology. 
3. Certification of the Multidisciplinary Uveitis Unit by the Madrid Rheumatology Society, which highlights the joint work of the Ophthalmology (Dr. Francisco José Muñoz Negrete) and Rheumatology (Dr. Mónica Vázquez Díaz) Departments in the multidisciplinary management of uveitis, consolidating its leadership in the diagnosis and treatment of these ocular inflammatory pathologies.
4. Participation in executive committees of international registries on keratoconus and dry eye. Francisco Arnalich is a member of the Steering Committee of the FRB Keratoconus Registry, an international network of hospitals dedicated to the development and analysis of a global registry on keratoconus. Likewise, together with David Mingo, he also participates in the Steering Committee of the FRB Dry Eye Registry, another international registry focused on the study of dry eye. 
5. Selected as the No. 1 Ophthalmology Service at national level by MERCO's Health Reputation Monitor (MRS), recognition that endorses excellence, quality of care and leadership in the sector.